Dr. Reddy's Laboratories Limited (NYSE: RDY) is set to announce its financial results for the second quarter of 2025 on Tuesday 5th November 2024. This highly anticipated announcement is scheduled to take place before market open. Investors will have the opportunity to learn more about the company's performance during the quarter.
The financial experts on Wall Street are predicting that the enterprise will likely report an estimated $0.99 profit per share for the second quarter. Additionally, it is anticipated that the company will reveal a $909.62 million revenue during the quarter.
The earnings report for the corresponding quarter of the prior year unveiled a per-share income of $1.07. This was a direct result of the company's total revenue, which amounted to an impressive $828 million during that specific period.
Financial experts on Wall Street have shared their predictions regarding the company's annual performance, estimating a total revenue of $3.69 billion. Additionally, they are expecting the company to report profit of $4.04 per share for the full year 2025.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q4 2024 | $0.94 | +34.3% | 850.00 M | +11.0% |
| Q3 2024 | $0.99 | +8.8% | 867.00 M | +5.1% |
| Q2 2024 | $1.07 | +30.5% | 828.00 M | +6.8% |
| Q1 2024 | $1.03 | +10.8% | 821.00 M | +21.5% |
| *Growth on year-over-year basis | ||||
During Friday's trading, Dr. Reddy's Laboratories Limited (RDY) shares reached a low of $73.94 and a high of $74.55, along with a total volume of 96.70 thousand shares. The stock ended the regular trading session at $74.27, indicating an increase of 0.50 percent.
